The Proximal Tubule as the Pathogenic and Therapeutic Target in Acute Kidney Injury

Area of Science:

• Nephrology
• Pathophysiology
• Mitochondrial Biology

Background:

• Acute kidney injury (AKI) replaced older terms like acute renal failure and acute tubular necrosis (ATN) in 2004.
• Despite terminology changes, the understanding of AKI mechanisms largely relies on ATN pathophysiology.
• The exact initiation mechanisms of AKI remain elusive.

Purpose of the Study:

• To investigate the role of the proximal tubule (PT) in the pathophysiology of AKI.
• To explore potential therapeutic targets within the PT for AKI treatment.

Main Methods:

• Analysis of PT vulnerability due to high mitochondrial content and reliance on oxidative phosphorylation.
• Evaluation of PT histological and physiological changes during AKI.
• Assessment of urinary and plasma biomarkers for early PT injury detection.
• Review of therapeutic agents targeting PT epithelial cells and mitochondria.

Main Results:

• The PT is highly susceptible to ischemic insults and mitochondrial dysfunction, showing consistent pathological changes in AKI.
• PT dysfunction impacts glomerular filtration via tubuloglomerular feedback.
• Urinary biomarkers indicate PT injury within 1 hour of shock, suggesting it as an early pathogenic target.
• Pharmacological interventions like frusemide are affected by PT dysfunction.

Conclusions:

• The proximal tubule is identified as the initiation pathogenic target in acute kidney injury.
• Therapeutic strategies targeting PT epithelial cells, particularly their mitochondria, demonstrate significant potential for AKI amelioration.